135
Views
7
CrossRef citations to date
0
Altmetric
Kidney

Xp11 translocation renal cell carcinoma

&
Pages 369-373 | Published online: 04 May 2010

References

  • Argani P, Antonescu CR, Couturier J, et al PRCC-TFE3 renal carcinomas: Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 2002; 26: 1553–1566.
  • Argani P, Antonescu CR, Illei PB, et al Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001; 159: 179–192.
  • Ladanyi M, Lui MY, Antonescu CR, et al The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001; 20: 48–57.
  • Clark J, Lu YJ, Sidhar SK, et al Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 1997; 15: 2233–2239.
  • Argani P, Lui MY, Couturier J, Bouvier R, Fournet J, Ladanyi M. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 2003; 22: 5374–5378.
  • Argani P, Olgac S, Tickoo SK, et al Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 2007; 31: 1149–1160.
  • Dijkhuizen T, van den Berg E, Wilbrink M, et al Distinct Xp11.2 breakpoints in two renal cell carcinomas exhibiting X;autosome translocations. Genes Chromosomes Cancer 1995; 14: 43–50.
  • Chian-Garcia CA, Torres-Cabala CA, Eyler R. Renal cell carcinoma in children and young adults: A clinicopathologic and immunohistochemical study of 14 cases. Mod Pathol 2003; 16: 145A.
  • Bruder E, Passera O, Harms D, et al Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol 2004; 28: 1117–1132.
  • Altinok G, Kattar MM, Mohamed A, Poulik J, Grignon D, Rabah R. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations. Pediatr Dev Pathol 2005; 8: 168–180.
  • Ramphal R, Pappo A, Zielenska M, Grant R, Ngan BY. Pediatric renal cell carcinoma: Clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol 2006; 126: 349–364.
  • Geller JI, Dome JS. Adjuvant therapy in pediatric patients with completely resected renal cell carcinoma. Pediatr Blood Cancer 2006; 46: 527.
  • Komai Y, Fujiwara M, Fujii Y, et al Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res 2009; 15: 1170–1176.
  • Zhong M, Osborne L, Merino MJ, Hameed M, Aisner S. The study of Xp11 translocation renal cell carcinoma (RCC) in adults by TMA, IHC and FISH. Mod Pathol 2010; 23(S1): 232A.
  • Argani P, Laé M, Ballard ET, et al Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol 2006; 24: 1529–1534.
  • Rais-Bahrami S, Drabick JJ, De Marzo AM, et al Xp11 translocation renal cell carcinoma: Delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology 2007; 70: 178.
  • Medeiros LJ, Palmedo G, Krigman HR, Kovacs G, Beckwith JB. Oncocytoid renal cell carcinoma after neuroblastoma: A report of four cases of a distinct clinicopathologic entity. Am J Surg Pathol 1999; 23: 772–780.
  • Tickoo SK, dePeralta-Venturina MN, Harik LR, et al Spectrum of epithelial neoplasms in end-stage renal disease: An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006; 30: 141–153.
  • Suzigan S, Drut R, Faria P, et al Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features. Int J Surg Pathol 2007; 15: 199–203.
  • Argani P, Hicks J, De Marzo A, et al Xp11 translocation renal cell carcinoma (RCC): Extended immunohistochemical (IHC) profile emphasizing novel RCC markers. Mod Pathol 2010; 23(S1): 175–176A.
  • Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: A sensitive and specific immunohistochemical assay. Am J Surg Pathol 2003; 27: 750–761.
  • Aulmann S, Longerich T, Schirmacher P, Mechtersheimer G, Penzel R. Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas. Histopathology 2007; 50: 881–886.
  • Motyckova G, Weilbaecher KN, Horstmann M, Rieman DJ, Fisher DZ, Fisher DE. Linking osteopetrosis and pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci USA 2001; 98: 5798–5803.
  • Martignoni G, Pea M, Gobbo S, et al Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol 2009; 22: 1016–1022.
  • Geller JI, Argani P, Adeniran A, et al Translocation renal cell carcinoma: Lack of negative impact due to lymph node spread. Cancer 2008; 112: 1607–1616.
  • Meyer PN, Clark JI, Flanigan RC, Picken MM. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am J Clin Pathol 2007; 128: 70–79.
  • Argani P, Aulmann S, Karanjawala Z, Fraser RB, Ladanyi M, Rodriguez MM. Melanotic Xp11 translocation renal cancers: A distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol 2009; 33: 609–619.
  • Chang IW, Huang HY, Sung MT. Melanotic Xp11 translocation renal cancer: A case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts. Am J Surg Pathol 2009; 33: 1894–1901.
  • Argani P, Illei P, Netto G, et al A subset of PEComas harbor TFE3 Gene fusions. Mod Pathol 2010; 23(S1): 15A.
  • Tanaka M, Kato K, Gomi K, et al Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma. Am J Surg Pathol 2009; 33: 1416–1420.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.